TATAA Biocenter and Strand Life Sciences Announce Strategic Partnership to Distribute Strand NGS in Europe

GÖTEBORG, Sweden and BANGALORE, India, June 23, 2015 /PRNewswire/ --

TATAA Biocenter to Also Introduce Strand NGS in its Popular NGS Training Courses  

TATAA Biocenter, the world's foremost organizer of hands-on training in molecular diagnostics and Europe's leading provider of genomic services, has partnered with Strand Life Sciences, the world leader in the implementation of bioinformatics in personalized medicine, to advance the analysis of Next Generation Sequencing (NGS) data. As part of the partnership, TATAA Biocenter will distribute and support Strand NGS, Strand's premier analysis tool for NGS data, in Europe. TATAA is also going to use Strand NGS in its popular NGS training courses.

"We always seek collaboration with the best solution providers for our training courses and Strand Life Sciences are top of the class for NGS whole transcriptome profiling," says Kristina Lind, coordinator of TATAA Biocenter's hands-on training program.

"Our customers request professional tools for the entire NGS workflow from sample preparation, quality control, library preparation, sequencing and data analysis," says Mikael Kubista, President of TATAA Biocenter. "With Strand NGS our customers obtain the most comprehensive and powerful tool for the analysis of Next Generation Sequencing data."

"We have always welcomed collaborations for serving the customer better and for the greater good of science. TATAA Biocenter is an established player in Europe with a wide reach. European customers will now have access to one of the most comprehensive, commercially available, NGS analysis tools," says Scott Storrer, President of Strand Life Science.

About TATAA Biocenter 

TATAA Biocenter is the world's largest organizer of hands-on training in molecular analyses, Europe's leading provider of nucleic acid analysis services, and Sweden's most comprehensive distributor of products for nucleic acids analysis. TATAA Biocenter offers hands-on training in all aspects of molecular analyses, biomarker research, and validation from experimental design, sample preparation, quality control, analysis and modelling. Through its laboratories in Göteborg, Sweden, and Prague, Czech Republic, and sales office in Saarbrücken, Germany, TATAA Biocenter supports its clients with products for the full range of nucleic acid and protein analyses and services in compliance with ISO17025 standard. In 2013 TATAA Biocenter was presented the Frost & Sullivan Award for Customer Value Leadership as Best-in-Class Services for Analyzing Genetic Material. For more information, see http://www.tataa.com or contact us on [email protected].

About Strand Life Sciences 

Founded in 2000, Strand is a personalized medicine company offering next-generation sequencing (NGS) based targeted multi-gene panels for cancer and other diseases. Strand works with oncologists, pathologists, community hospitals, and biopharmaceutical companies to enable faster clinical decision support for accurate molecular diagnosis, prognosis, therapy recommendations and clinical trials. For larger hospital systems, Strand offers an innovative customizable turnkey solution called Strand SmartLab. Strand's genomics solutions are used at over 2,000 research laboratories and 100 hospitals world-wide. Strand develops and offers NGS based genetic and genomic tests for cancer and other diseases from the company's central reference laboratories in Aurora, Colorado, and Bangalore, India. For more information, visit http://www.strandls.com.

Media Contact:  

David Schull
[email protected]
(212) 845-4271
Russo Partners, LLC

Todd Davenport, Ph.D.
[email protected]
(212) 845-4235
Russo Partners, LLC

SOURCE Strand Life Sciences